Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40199-021-00390-z http://scihub22266oqcxt.onion/10.1007/s40199-021-00390-z 33715138!7955799!33715138     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Daru 2021 ; 29 (1): 217-221 Nephropedia Template TP {{tp|p=33715138|t=2021. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19 |pdf=|usr=}}{{33715138}} gab.com Text Surging trends in prescriptions and costs of antidepressants in England amid COVID-19 JO: Daru http://www.kidney.de/pget.php?&tw=1&pmid=33715138 #FOAvip The social restrictions amid coronavirus disease 2019 (COVID-19) pandemic have posed a serious threat to mental health and have implications in the use of medications for mental health including antidepressants (ADs). This study investigated the trends in prescriptions and costs of various ADs in England during COVID-19 pandemic. National prescribing rates and net ingredient costs (NIC) of all ADs prescriptions during 2016 to 2020 were analyed. The total number of ADs prescriptions dispensed during COVID-19 pandemic (January to December 2020) were 78 million, 4 million more than in 2019 that costed NHS England pound 139 million more than in 2019. Sertraline, an SSRI antidepressant drug, alone accounted for an extra pound113 million during 2020 than in 2019. The peak dispensing for ADs was observed in March 2020 while the total costs for AD drugs peaked in April 2020. The rising prescription costs for ADs during COVID-19 pandemic is a potential cause of concern, in particular the increasing use in adolescents and younger adults needs attention, who are at a higher risk of life-threatening adverse drug reactions. Twit Text FOAVip Surging trends in prescriptions and costs of antidepressants in England amid COVID-19 ????Daru http://www.kidney.de/pget.php?&tw=1&pmid=33715138 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33715138 #FOAvip English Wikipedia <ref>{{Cite pmid|33715138}}</ref> Surging trends in prescriptions and costs of antidepressants in England amid COVID-19 #MMPMID33715138 Rabeea SA; Merchant HA; Khan MU; Kow CS; Hasan SS Daru 2021[Jun]; 29 (1): 217-221 PMID33715138show ga The social restrictions amid coronavirus disease 2019 (COVID-19) pandemic have posed a serious threat to mental health and have implications in the use of medications for mental health including antidepressants (ADs). This study investigated the trends in prescriptions and costs of various ADs in England during COVID-19 pandemic. National prescribing rates and net ingredient costs (NIC) of all ADs prescriptions during 2016 to 2020 were analyed. The total number of ADs prescriptions dispensed during COVID-19 pandemic (January to December 2020) were 78 million, 4 million more than in 2019 that costed NHS England pound 139 million more than in 2019. Sertraline, an SSRI antidepressant drug, alone accounted for an extra pound113 million during 2020 than in 2019. The peak dispensing for ADs was observed in March 2020 while the total costs for AD drugs peaked in April 2020. The rising prescription costs for ADs during COVID-19 pandemic is a potential cause of concern, in particular the increasing use in adolescents and younger adults needs attention, who are at a higher risk of life-threatening adverse drug reactions. |Antidepressive Agents/*economics/therapeutic use[MESH] |COVID-19/*economics/*epidemiology[MESH] |Depression/drug therapy/economics/epidemiology[MESH] |Drug Costs/*trends[MESH] |Drug Prescriptions/*economics[MESH] |England/epidemiology[MESH]Surging trends in prescriptions and costs of antidepressants in Englan(epmc).pdf DeepDyve Pubget Overpricing